In the realm of molecular biology and protein biochemistry, achieving precise, site-specific modification is a cornerstone of experimental success. One of the most elegant tools for this purpose is the BirA acceptor peptide sequence. Through my personal experience working with enzymatic labeling systems, I have found that understanding the by A Predonzani·2008·Cited by 89—Upstream of the cDNA encodingBirA, a signal secretion leadersequencewas added to allow translocation of the enzyme to the secretory pathway.Read more nuances of these tags is essential for anyone looking to achieve consistent results in by I Chen·2007—E. coli biotin ligase (BirA) catalyzes the site-specific ligation of biotin to the lysine within its 15-amino acid peptidesubstrate (AP).Read more their workflows.
The Foundation: What is the BirA Acceptor Peptide?
The process revolves around the *E. coli* bi by I Chen·2007—E. coli biotin ligase (BirA) catalyzes the site-specific ligation of biotin to the lysine within its 15-amino acid peptidesubstrate (AP).Read more otin ligase, known as BirA. This enzyme acts as a biotin--[biotin carboxyl-carrier protein] ligase, which naturally functions to attach biotin to a specific lysine residue within the biotin carboxyl-carrier protein (BCCP).
Researchers have successfully minimized this natural recognition motif into a short amino acid sequence that can be fused to a protein of interest. This acceptor peptide—often referred to as the AviTag—is a 15-amino acid acceptor peptide (GLNDIFEAQKIEWHE). While early research identified the 13 amino acid sequence as the minimum requirement for recognition, the extended 15-mer is now the standard for high-efficiency labeling.
Why Use a BirA Acceptor Peptide?
When I first transitioned from chemical labeling to enzymatic methods, the differenc Labeling Cell Surface Receptors with Ligand.BirA* Bispecifics e in specificity was striking. Chemical biotinylation can often result in multiple biotin molecules attached to various surface lysines, which can interfere with protein function. In contrast, Biotin ligase (BirA) ligates biotin specifically to a biotin acceptor peptide, ensuring that the amino acid modificat In another embodiment, theacceptor peptidecomprises anamino acid sequenceof SEQ ID NO: 5. Theacceptor peptidemay be N- or C-terminally fused to the target Read more ion occurs at exactly one residue.
Key takeaways from my trials include:
* Precision: Because BirA adds d-biotin covalently to biotin-acceptor peptides at a single site, you avoid the heterogeneity associated with non-specific chemical reactions.
* Versatility: The acceptor peptide can be placed at the N- or C-terminus, or even internally, provided the protein structure allows for it.
* Efficiency: Using an optimized peptide sequence allows for high-throughput ap Efficient biotinylation and single-step purification of tagged plications, which is vital when screening multiple constructs.
Technical Considerations for Implementation
When working with this system, the sequence composition of the tag is critical. The central lysine within the amino-acid peptide is the target. If you are designing your own fusion proteins, ensure that the flanking regions do not create steric hindrance that might block the enzyme's access.
I have observed that the performance of this peptide can be influenced by the expression host. Whether you are expressing in *E. coli* or mammalian systems, the BirA enzyme must be present in sufficient concentration to catalyze the reaction. Some protocols involve co-expression of the ligase, while others utilize purified enzyme for *in vitro* labeling.
Practical Tips for Success
1. Sequence Integrity: Always verify your amino acid sequence after cloning. Given that the 13 amino acid sequence is the core, even a single point mutation can abolish the recognition by the enzyme.
2. Buffer Optimization: The BirA enzyme requires ATP and biotin in the reaction buffer. I recommend testing different concentrations to ensure the biotin-acceptor peptide is fully labeled.
3. Entity Awareness: Remember that several peptide sequences have been described for BirA-mediated biotinylation. While the AviTag is the most common, always check the literature if you are working with non-standard variants.
4. Verification: Use a simple pull-down assay or Western blot with streptavidin-HRP to confirm that your acceptor peptide has been successfully biotinylate Site-specific labeling of cellular proteins with unnatural d.
By focusing on the BirA recognition motif and ensuring the peptide sequence is correctly incorporated into your protein construct, you can achieve highly reproducible labeling. This method remains one of the most reliable ways to handle protein tags, providing a clean, site-specific result every time.